You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Plasma Protease C1-inhibitor Treatment Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Plasma Protease C1-inhibitor Treatment market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Plasma Protease C1-inhibitor Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Drug Class
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Selective Bradykinin B2 Receptor Antagonist (Firazyr)
By Dosage Type
Liquid/Injectable
Lyophilized

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Shire plc
CSL Limited
Sanquin
Pharming Group N.V.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital Pharmacies
Independent Pharmacies and Outlets

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Plasma Protease C1-inhibitor Treatment Industry
Figure Plasma Protease C1-inhibitor Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Plasma Protease C1-inhibitor Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Plasma Protease C1-inhibitor Treatment
1.2.2 Downstream
Table Application Segment of Plasma Protease C1-inhibitor Treatment
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Plasma Protease C1-inhibitor Treatment Market by Drug Class
3.1 By Drug Class
3.1.1 C1-inhibitors
Table Major Company List of C1-inhibitors
3.1.2 Kallikrein Inhibitor (Kalbitor)
Table Major Company List of Kallikrein Inhibitor (Kalbitor)
3.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
Table Major Company List of Selective Bradykinin B2 Receptor Antagonist (Firazyr)
3.2 By Dosage Type
Table Major Company List of Liquid/Injectable
Table Major Company List of Lyophilized
3.3 Market Size
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Drug Class, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2016-2020, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Drug Class, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2016-2020, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Dosage Type, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2016-2020, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Dosage Type, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2016-2020, by Dosage Type, in Volume
3.4 Market Forecast
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Dosage Type, in Volume
4 Major Companies List
4.1 Shire plc (Company Profile, Sales Data etc.)
4.1.1 Shire plc Profile
Table Shire plc Overview List
4.1.2 Shire plc Products & Services
4.1.3 Shire plc Business Operation Conditions
Table Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 CSL Limited (Company Profile, Sales Data etc.)
4.2.1 CSL Limited Profile
Table CSL Limited Overview List
4.2.2 CSL Limited Products & Services
4.2.3 CSL Limited Business Operation Conditions
Table Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Sanquin (Company Profile, Sales Data etc.)
4.3.1 Sanquin Profile
Table Sanquin Overview List
4.3.2 Sanquin Products & Services
4.3.3 Sanquin Business Operation Conditions
Table Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Pharming Group N.V. (Company Profile, Sales Data etc.)
4.4.1 Pharming Group N.V. Profile
Table Pharming Group N.V. Overview List
4.4.2 Pharming Group N.V. Products & Services
4.4.3 Pharming Group N.V. Business Operation Conditions
Table Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue 2016-2020, by Company, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Sales Revenue Share in 2020, by Company, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Sales Volume 2016-2020, by Company, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2020
Figure Europe Plasma Protease C1-inhibitor Treatment Market Market Concentration, in 2020
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment MMarket Concentration, in 2020
Figure South America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2020
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacies
Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2016-2020, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2016-2020, in Volume
6.1.2 Demand in Independent Pharmacies and Outlets
Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2016-2020, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2021-2026, by Application, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Market Growth 2021-2026, by Application, in USD Million
Figure Plasma Protease C1-inhibitor Treatment Market Share in 2026, by Application, in USD Million
Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2021-2026, by Application, in Volume
Table Plasma Protease C1-inhibitor Treatment Market Growth 2021-2026, by Application, in Volume
Table Plasma Protease C1-inhibitor Treatment Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Plasma Protease C1-inhibitor Treatment Production 2016-2020, by Region, in USD Million
Table Plasma Protease C1-inhibitor Treatment Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Region, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Share 2016-2020, by Region, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2016-2020, by Region, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in USD Million
Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in USD Million
Table North America Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in USD Million
Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in USD Million
Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in USD Million
Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in USD Million
Table South America Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Region, in USD Million
Table Plasma Protease C1-inhibitor Treatment Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 89